https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50387 75 % of participant agreement. Results: The consensus DOOR comprised four main dimensions. The primary dimension was patient-reported joint function. The secondary dimensions were infection cure and mortality. The final dimension of quality of life was selected as a tie-breaker. Discussion: A desirability of outcome ranking for periprosthetic joint infection has been proposed. It focuses on patient-centric outcome measures of joint function, cure and quality of life. This DOOR provides a multidimensional assessment to comprehensively rank outcomes when comparing treatments for prosthetic joint infection.]]> Mon 24 Jul 2023 14:12:35 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51580 1 month with <7 days symptoms, chronic >1 month with >7 days symptoms) classifications. Results: DAIR success was 45% (85/189) and was highest in early PJIs defined according to the Coventry (adjusted odds ratio [aOR] = 3.9, P =.01), the International Consensus Meeting (aOR = 3.1, P =.01), and the Auckland classifications (aOR = 2.6, P =.01). Success was lower in both hematogenous (aOR = 0.4, P =.03) and chronic infections (aOR = 0.1, P =.003). Conclusion: Time since primary TKA is an important predictor of DAIR success. Success was highest in infections occurring <1 month of the primary TKA and progressively decreased as time since the primary TKA increased.]]> Mon 11 Sep 2023 14:30:45 AEST ]]>